Voglistar GM2 Tablet

Voglistar Gm2 Tablet contains Voglibose 0.2 mg + Metformin Hydrochloride 500 mg (as sustained release) + Glimepiride 2 mg. Prescription required.

Type 2 diabetes mellitus (when diet and exercise alone are not enough), especially in patients requiring triple therapy to control post‑meal and fasting blood glucose

Voglibose inhibits intestinal alpha‑glucosidase enzymes, delaying carbohydrate digestion and reducing post‑meal blood glucose spikes. Metformin decreases hepatic glucose production and improves insulin sensitivity. Glimepiride stimulates insulin release from pancreatic beta cells to lower blood glucose.

Tablet (oral). Take exactly as prescribed, usually once daily with the first main meal; swallow whole with water (do not crush/chew as it contains sustained‑release metformin). Follow diet/exercise advice and monitor blood glucose regularly.

Hypoglycaemia, nausea, vomiting, diarrhoea, abdominal pain, flatulence, loss of appetite, headache, dizziness, metallic taste

Risk of hypoglycaemia (more likely with missed meals, excess exercise, alcohol, or with other antidiabetics); carry glucose/sugar. Metformin may rarely cause lactic acidosis—seek urgent care for fast breathing, severe weakness, abdominal pain, or drowsiness; higher risk with kidney/liver impairment, dehydration, severe infection, or excessive alcohol. Avoid/consult doctor if severe renal impairment; kidney function monitoring recommended. Temporarily stop metformin before/after iodinated contrast procedures or major surgery as advised. Use caution in elderly and in patients with G6PD deficiency (risk of hemolysis with sulfonylureas).

Insulin/other antidiabetics (increased hypoglycaemia), alcohol (increased hypoglycaemia and lactic acidosis risk), iodinated contrast media (lactic acidosis risk), diuretics and ACE inhibitors/ARBs (may alter glucose and affect renal function), corticosteroids and thiazides (may raise glucose), beta‑blockers (may mask hypoglycaemia symptoms), cimetidine (may increase metformin levels)

Store below 25°C, protected from light and moisture. Keep in original blister pack and out of reach of children.

Voglibose 0.2 mg + Metformin SR 500 mg + Glimepiride 2 mg tablets (generic), Voglibose-MG 0.2/500/2 (brand equivalents may vary), Vogli-M2 Forte (brand equivalents may vary), Tripride-VG 2 (brand equivalents may vary), Glycomet-GP-V 2 (brand equivalents may vary)